The field of vaccine research is an ongoing topic for those involved in the Biotech Industry and Clinical Research. Many diseases such as smallpox have become eradicated due to modern vaccination programmes. Vaccines have emerged as one of the most lucrative segments in the Global Pharmaceutical Industry with a prospective CAGR (Compound Annual Growth Rate) of 13% during 2009 - 2012.
We are pleased to invite you to the HCR Spring Vaccine Symposium on the risk analysis of clinical research on vaccines. The following experts will give a presentation and are available for our Round-Table discussion:

• Dr. Anne-Marie Georges, with 21 + years of experience in regulatory affairs in the vaccine industry, will speak about safety challenges in the clinical development of vaccines;
• Dr. Michael Pfleiderer, Department of Viral Vaccines, Paul-Ehrlich Institut, Germany, will speak on the risk analysis during clinical trials of vaccines from the point of view of regulatory affairs;
• Dr. Stephan de la Motte, Chief Medical Officer, Harrison Clinical Research Deutschland GmbH, will speak on the risk analysis during clinical trials of vaccines from the point of view of the investigator.

Please complete the registration form by 8 March and return it to us using the "Registration" button. We look forward to seeing you in Munich on 18. March 2010, at our HCR Spring Vaccine Symposium.